市場調査レポート

商品コード

1619126

臓器オンチップ市場規模、シェア、成長分析、臓器タイプ別、モデルタイプ別、製品別、目的別、用途別、エンドユーザー別、地域別 - 産業予測、2024～2031年

Organ On Chip Market Size, Share, Growth Analysis, By Organ Type (Liver, Kidney), By Model Type (Organ-Based Models, Disease-Based Models), By Product, By Purpose, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年12月19日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

臓器オンチップの世界市場規模は、2022年に1億2,000万米ドルと評価され、2023年の1億6,224万米ドルから2031年には18億1,122万米ドルに成長し、予測期間（2024～2031年）のCAGRは35.2％で成長する見通しです。

臓器オンチップ市場は、技術の進歩や製薬、バイオテクノロジー、学術分野での採用拡大により急成長を遂げており、動物実験代替の需要や早期薬物反応検出の必要性がその背景にあります。このマイクロ流体細胞培養装置は、臓器機能をシミュレートし、疾患モデリング、薬剤設計、毒性試験において多様な用途を提供します。特筆すべきは、ISS国立研究所に送られたエミュレート社のブレイン・チップのような最近の取り組みが、この技術の革新的な可能性を浮き彫りにしていることです。COVID-19後の情勢は、利害関係者がヘルスケア環境内での臓器応用の拡大を目指しているため、この需要をさらに強めています。その結果、世界の臓器オンチップ市場は予測期間中にCAGR 30.76%という目覚ましい成長を遂げ、医薬品開発と調査手法を再構築すると予測されています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021～2023年）

主要企業プロファイル

Emulate, Inc.
Mimetas B.V.
Tissuse GmbH
CN Bio Innovations Ltd.
InSphero
Alveolix AG
Fluigent

結論と推奨事項

Product Code: SQMIG35A2896

Global Organ On Chip Market size was valued at USD 120.0 million in 2022 and is poised to grow from USD 162.24 million in 2023 to USD 1811.22 million by 2031, growing at a CAGR of 35.2% during the forecast period (2024-2031).

The organ-on-a-chip market is witnessing rapid growth due to technological advancements and increased adoption across pharmaceutical, biotechnology, and academic sectors, driven by the demand for alternatives to animal testing and the need for early drug reaction detection. This microfluidic cell culture device simulates organ functions and offers diverse applications in disease modeling, drug design, and toxicity testing. Notably, recent initiatives, such as Emulate, Inc.'s Brain Chip sent to the ISS National Lab, highlight the technology's innovative potential. The post-COVID-19 landscape has further intensified this demand, as stakeholders aim to expand organ applications within healthcare settings. Consequently, the global organ-on-a-chip market is projected to grow at a remarkable CAGR of 30.76% during the forecast period, reshaping drug development and research methodologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Organ On Chip market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Organ On Chip Market Segmental Analysis

Global Organ On Chip Market is segmented by organ type, model type, product, purpose, application, end user and region. Based on organ type, the market is segmented into liver, kidney, intestine, lung, heart and other organs. Based on model type, the market is segmented into organ-based models and disease-based models. Based on product, the market is segmented into services and products. Based on purpose, the market is segmented into therapeutics and research. Based on application, the market is segmented into toxicology research, drug discovery, physiological model development, tissue regeneration & regenerative medicine and stem cell research. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, cosmetics industry, academic & research institutes and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Organ On Chip Market

The Global Organ-On-Chip market is significantly driven by the growing demand for animal-free testing solutions. As awareness regarding ethical considerations and animal welfare continues to increase among consumers globally, there is a strong advocacy for alternatives to traditional testing methods. Organ-on-chip technologies are emerging as vital tools in drug discovery and toxicity assessments, offering reliable and humane options for researchers. This shift towards innovative, non-animal testing platforms is likely to provide substantial momentum to the market, as organizations seek to align with consumer preferences while enhancing the efficiency and accuracy of their scientific evaluations.

Restraints in the Global Organ On Chip Market

The Global Organ-On-Chip market faces significant restraints due to various ethical and societal challenges. Chief among these concerns are the ethical implications related to the use of human cells, tissues, and organs in research, which raise questions about informed consent, privacy, and the ethical sourcing of biological materials. It is crucial to navigate these ethical, legal, and societal issues responsibly, particularly regarding animal welfare. Addressing these challenges is vital for fostering sustainable growth and development in the market, as stakeholders must ensure that their practices align with ethical standards while promoting innovation and accessibility in organ-on-chip technology.

Market Trends of the Global Organ On Chip Market

The Global Organ-On-Chip market is witnessing a notable trend towards enhancing the accuracy of drug predictions, driven by escalating R&D costs and waning effectiveness in pharmaceuticals. As drug development faces critical challenges, companies are increasingly adopting organ-on-chip technologies to simulate human organ responses accurately, thereby reducing dependence on traditional animal testing. This innovative approach not only streamlines the drug development process but also improves safety assessments and efficacy predictions. The growing demand for personalized medicine and regulatory pressure for better predictive models further propels market growth, positioning organ-on-chip solutions as a pivotal tool for the future of pharmaceutical research and development.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Case Study Analysis
Trade Analysis
Customer & Buying Criteria Analysis

Global Organ On Chip Market Size by Organ Type & CAGR (2024-2031)

Market Overview
Liver
Kidney
Intestine
Lung
Heart
Other Organs

Global Organ On Chip Market Size by Model Type & CAGR (2024-2031)

Market Overview
Organ-Based Models
Disease-Based Models

Global Organ On Chip Market Size by Product & Service & CAGR (2024-2031)

Market Overview
Services
- Custom Services
- Standard Services
Products
- Instruments
- Consumables & Accessories
- Software

Global Organ On Chip Market Size by Purpose & CAGR (2024-2031)

Market Overview
Therapeutics
Research

Global Organ On Chip Market Size by Application & CAGR (2024-2031)

Market Overview
Toxicology Research
Drug Discovery
Physiological Model Development
Tissue Regeneration & Regenerative Medicine
Stem Cell Research

Global Organ On Chip Market Size by End User & CAGR (2024-2031)

Market Overview
Pharmaceutical and Biotechnology Companies
Cosmetics Industry
Academic & Research Institutes
Other End Users

Global Organ On Chip Market Size & CAGR (2024-2031)

North America (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- US
- Canada
Europe (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Organ Type, Model Type, Product & Service, Purpose, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Emulate, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mimetas B.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tissuse GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CN Bio Innovations Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InSphero
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alveolix AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluigent
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

臓器オンチップ市場規模、シェア、成長分析、臓器タイプ別、モデルタイプ別、製品別、目的別、用途別、エンドユーザー別、地域別 - 産業予測、2024～2031年

Organ On Chip Market Size, Share, Growth Analysis, By Organ Type (Liver, Kidney), By Model Type (Organ-Based Models, Disease-Based Models), By Product, By Purpose, By Application, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

臓器オンチップ市場規模：臓器タイプ別およびCAGR（2024～2031年）

臓器オンチップ市場規模：モデルタイプ別およびCAGR（2024～2031年）

臓器オンチップ市場規模：製品・サービス別およびCAGR（2024～2031年）

臓器オンチップ市場規模：目的別およびCAGR（2024～2031年）

臓器オンチップ市場規模：用途別およびCAGR（2024～2031年）

臓器オンチップ市場規模：エンドユーザー別およびCAGR（2024～2031年）

臓器オンチップ市場規模およびCAGR（2024～2031年）